Equity Profile

VTRS

Viatris Inc.

Health CarePharmaceuticals$18.9B

May7Thu

Post-Earnings Recap

ReportedQ1-2026Pre-Market6:59 AM EDT

Viatris Inc. Beats on EPS, Stock Up 0.00%

Metric	Actual	Expected	Surprise
EPS	$0.59	$0.50	+13.46%
Revenue	—	$3.4B	—

management commentary, guidance changes, and full analysis available with Pro.

Viatris Inc. Beats on EPS, Stock Up 0.00%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$0.59	$0.50	+13.46%
Revenue	—	$3.4B	—

Management Commentary

Tone: Unknown

No transcript is on record for this earnings call, so the analysis is based solely on the numerical results.

What It Means

Viatris Inc. reported better-than-expected earnings per share, which indicates stronger profitability than analysts anticipated. However, the stock reaction remained flat, suggesting that investors may be cautious or waiting for more information. The lack of revenue data and management commentary leaves some uncertainty about the company's overall performance and future outlook.

Company Snapshot

Viatris Inc. (VTRS) operates in the health care sector, focusing on pharmaceuticals....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and is closely watched by investors.

0.50

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

3.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Viatris Inc. (VTRS) operates in the health care sector, focusing on pharmaceuticals. The company plays a crucial role in providing access to medicines, which is increasingly important in today's health-conscious environment.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+6.19%

Avg Stock Reaction

+1.97%

Last Quarter Recap

In Q4-2025, Viatris reported an EPS of $0.57, exceeding expectations by 9.62%. However, the stock dropped 5.16% the following day, indicating market skepticism despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Viatris to report an EPS of $0.50 and revenue of $3.4 billion for Q1-2026. The market is looking for signs of continued growth amidst competitive pressures.

Bull Case

If Viatris can beat EPS estimates and show strong revenue growth, it could signal robust demand for its products, boosting investor confidence.

Bear Case

Conversely, if the company misses earnings expectations or provides weak guidance, it could raise concerns about its growth trajectory and lead to a significant stock decline.

Key Metrics to Watch

EPS

0.50

Earnings per share is a key indicator of the company's profitability and is closely watched by investors.

Revenue

3.4B

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Viatris achieve an EPS of at least $0.50?

This figure is crucial for maintaining investor confidence and could influence stock performance significantly.

What guidance will management provide for future revenue growth?

Investors will be looking for clarity on how the company plans to navigate competitive pressures and market conditions.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Viatris' ability to capitalize on emerging markets and new product launches, which could drive higher revenue growth than anticipated.

Supporting Evidence

The company's recent earnings history shows a strong beat rate of 75%, indicating potential for positive surprises.

Options pricing suggests a lower expected move compared to historical averages, which may not fully account for upcoming growth catalysts.

Key Risk

If Viatris can demonstrate strong revenue growth from new products, it could invalidate the cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Viatris can sustain its earnings momentum amidst increasing competition and market challenges.

Bull Confirmed If

An EPS of $0.55 or higher would confirm strong operational performance and market demand.

Bear Confirmed If

An EPS below $0.48 would raise concerns about the company's growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±6.82%

Historical Avg

±8.6%

In line with history

The options market is pricing in a move of about 6.82%, suggesting that traders expect some volatility around the earnings announcement.

Options are pricing ±9.6% while VTRS has averaged ±8.6% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.7%

30d HV

27.6%

Calls (134K)P/C Ratio: 0.59Puts (61K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: X of Y (Z%)

This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 3.3%, with a raw directional average of +2.1% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Viatris beats expectations, history suggests the stock could rise by around 3.66%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors assess future guidance.

Miss

A miss could lead to a decline of about 10.10%, reflecting investor disappointment and concerns about the company's trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on competitive pressures and market share.
3Insights into cost management strategies and their effect on margins.
4Any discussion about international market performance and growth opportunities.
5Guidance on future earnings and revenue expectations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

AXSOME THERAPEUTICS

Company Snapshot

Viatris Inc. (VTRS) operates in the health care sector, focusing on pharmaceuticals....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and is closely watched by investors.

0.50

Revenue

Revenue figures provide insight into the company's sales performance and market demand for its products.

3.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+6.19%

Avg Stock Reaction

+1.97%

Last Quarter Recap

In Q4-2025, Viatris reported an EPS of $0.57, exceeding expectations by 9.62%. However, the stock dropped 5.16% the following day, indicating market skepticism despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Viatris to report an EPS of $0.50 and revenue of $3.4 billion for Q1-2026. The market is looking for signs of continued growth amidst competitive pressures.

Bull Case

If Viatris can beat EPS estimates and show strong revenue growth, it could signal robust demand for its products, boosting investor confidence.

Bear Case

Conversely, if the company misses earnings expectations or provides weak guidance, it could raise concerns about its growth trajectory and lead to a significant stock decline.

Key Metrics to Watch

EPS

0.50

Earnings per share is a key indicator of the company's profitability and is closely watched by investors.

Revenue

3.4B

Revenue figures provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Viatris achieve an EPS of at least $0.50?

This figure is crucial for maintaining investor confidence and could influence stock performance significantly.

What guidance will management provide for future revenue growth?

Investors will be looking for clarity on how the company plans to navigate competitive pressures and market conditions.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Viatris' ability to capitalize on emerging markets and new product launches, which could drive higher revenue growth than anticipated.

Supporting Evidence

The company's recent earnings history shows a strong beat rate of 75%, indicating potential for positive surprises.

Options pricing suggests a lower expected move compared to historical averages, which may not fully account for upcoming growth catalysts.

Key Risk

If Viatris can demonstrate strong revenue growth from new products, it could invalidate the cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Viatris can sustain its earnings momentum amidst increasing competition and market challenges.

Bull Confirmed If

An EPS of $0.55 or higher would confirm strong operational performance and market demand.

Bear Confirmed If

An EPS below $0.48 would raise concerns about the company's growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±6.82%

Historical Avg

±8.6%

In line with history

The options market is pricing in a move of about 6.82%, suggesting that traders expect some volatility around the earnings announcement.

Options are pricing ±9.6% while VTRS has averaged ±8.6% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.7%

30d HV

27.6%

Calls (134K)P/C Ratio: 0.59Puts (61K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: X of Y (Z%)

This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 3.3%, with a raw directional average of +2.1% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Viatris beats expectations, history suggests the stock could rise by around 3.66%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors assess future guidance.

Miss

A miss could lead to a decline of about 10.10%, reflecting investor disappointment and concerns about the company's trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on competitive pressures and market share.
3Insights into cost management strategies and their effect on margins.
4Any discussion about international market performance and growth opportunities.
5Guidance on future earnings and revenue expectations.